Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

April 15, 2023

Study Completion Date

May 15, 2023

Conditions
GlaucomaGlaucoma; DrugsOcular Surface Disease
Interventions
DIAGNOSTIC_TEST

Intraocular pressure (IOP)

Measurement of intraocular pressure in both eyes of the study population using the Goldman applanation tonometer.

DIAGNOSTIC_TEST

Tear Break-up Time (TBUT)

TBUT will be calculated after instillation of a drop of fluorescein dye, by slit lamp biomicroscopy.

DIAGNOSTIC_TEST

Conjuctival Hyperemia

Conjunctival hyperemia will be assessed by slit lamp biomicroscopy using a validated grading system.

DIAGNOSTIC_TEST

Schirmer Test

Schirmer test will be performed on both eyes to asses tear production.

DIAGNOSTIC_TEST

Visual Fields and OCT RNFL

Visual field examination using a Humphrey perimeter and measurement of peripapillary retinal nerve fiber layer thickness with optical coherence tomography.

Trial Locations (1)

68100

Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupoli

All Listed Sponsors
lead

Democritus University of Thrace

OTHER